Bill & Melinda Gates Foundation
Africa to get state-of-art HIV drugs for $75 per patient a year
The drug was originally developed by ViiV Healthcare, the HIV business majority-owned by GlaxoSmithKline (GSK.L). ViiV has offered licensing deals to generic companies to sell low-cost versions of the medicine in poor countries.
Progress of Nigeria, others against poverty, disease in jeopardy, says report
“We have investments in many states. Our focused delivery programmes are concentrated in Kaduna and Kano. We also have significant investments / engagement in Niger, Lagos, Borno, Yobe, Sokoto, and Bauchi states.